ReviewFrontiers in pharmacology2025

Nanocarrier-based targeted drug delivery for Alzheimer's disease: addressing neuroinflammation and enhancing clinical translation.

Kang Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.